6OT1 image
Deposition Date 2019-05-02
Release Date 2019-08-07
Last Version Date 2024-11-13
Entry Detail
PDB ID:
6OT1
Keywords:
Title:
Cryo-EM structure of vaccine-elicited antibody 0PV-b.01 in complex with HIV-1 Env BG505 DS-SOSIP and antibodies VRC03 and PGT122
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.50 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Envelope glycoprotein gp41
Gene (Uniprot):env
Chain IDs:A (auth: B), I (auth: O), Q (auth: D)
Chain Length:153
Number of Molecules:3
Biological Source:Human immunodeficiency virus 1
Polymer Type:polypeptide(L)
Molecule:BG505 gp120
Gene (Uniprot):env
Chain IDs:B (auth: G), J (auth: E), R (auth: P)
Chain Length:480
Number of Molecules:3
Biological Source:Human immunodeficiency virus 1
Polymer Type:polypeptide(L)
Molecule:0PV-b.01 heavy
Chain IDs:C (auth: H), K (auth: A), S (auth: M)
Chain Length:230
Number of Molecules:3
Biological Source:Macaca mulatta
Polymer Type:polypeptide(L)
Molecule:0PV-b.01 light
Chain IDs:D (auth: L), L (auth: C), T (auth: N)
Chain Length:219
Number of Molecules:3
Biological Source:Macaca mulatta
Polymer Type:polypeptide(L)
Molecule:PGT122 heavy
Chain IDs:E (auth: m), M (auth: F), U (auth: Q)
Chain Length:235
Number of Molecules:3
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:PGT122 light
Chain IDs:F (auth: n), N (auth: I), V (auth: R)
Chain Length:213
Number of Molecules:3
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:VRC03 heavy
Chain IDs:G (auth: q), O (auth: J), W (auth: S)
Chain Length:233
Number of Molecules:3
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:VRC03 light
Chain IDs:H (auth: r), P (auth: K), X (auth: T)
Chain Length:209
Number of Molecules:3
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation

Abstact

The vaccine-mediated elicitation of antibodies (Abs) capable of neutralizing diverse HIV-1 strains has been a long-standing goal. To understand how broadly neutralizing antibodies (bNAbs) can be elicited, we identified, characterized, and tracked five neutralizing Ab lineages targeting the HIV-1-fusion peptide (FP) in vaccinated macaques over time. Genetic and structural analyses revealed two of these lineages to belong to a reproducible class capable of neutralizing up to 59% of 208 diverse viral strains. B cell analysis indicated each of the five lineages to have been initiated and expanded by FP-carrier priming, with envelope (Env)-trimer boosts inducing cross-reactive neutralization. These Abs had binding-energy hotspots focused on FP, whereas several FP-directed Abs induced by immunization with Env trimer-only were less FP-focused and less broadly neutralizing. Priming with a conserved subregion, such as FP, can thus induce Abs with binding-energy hotspots coincident with the target subregion and capable of broad neutralization.

Legend

Protein

Chemical

Disease

Primary Citation of related structures